COMMUNIQUÉS West-GlobeNewswire

ChromaDex to Present at the 10th Annual LD Micro Main Event

29/11/2017 - 12:30

IRVINE, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), a science-based, fully integrated nutraceutical company devoted to extending human healthspan, announced today that its Chief Executive [...]

United Health Products Announces Medical Device Approval for HemoStyp® in South African Market

29/11/2017 - 12:00

HENDERSON, Nev., Nov. 29, 2017 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), a manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today [...]

Zealand Pharma to attend three U.S. healthcare conferences in December

29/11/2017 - 10:38

Press release - No. 12 / 2017 Zealand Pharma to attend three U.S. healthcare conferences in December Copenhagen, November 29, 2017 - Britt Meelby Jensen, President and Chief Executive Officer (CEO) and Mats Blom, [...]

Trading by management and of close relations to management

29/11/2017 - 10:33

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the [...]

Management change at ALK

29/11/2017 - 08:26

Copenhagen, 2017-11-29 08:26 CET (GLOBE NEWSWIRE) -- ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) today announced that Helle Skov, Executive Vice President (EVP) of Product Supply and a member of ALK's Board of [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

29/11/2017 - 07:01

REGULATED INFORMATION GHENT, Belgium, 29 November 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

MedMira Reports 2017 Fourth Quarter and Year End Financial Results

29/11/2017 - 00:45

HALIFAX, Nova Scotia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter and year ended July 31, 2017. MedMira’s Chief Financial Officer, Markus [...]

Cesca Therapeutics Inc. Announces Proposed Public Offering of Common Stock

28/11/2017 - 23:20

RANCHO CORDOVA, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today [...]

VANC Pharmaceuticals Closes Oversubscribed Private Placement

28/11/2017 - 23:02

VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. ( “VANC” or the “Company” ) (TSX-V: VANC ) (OTCQB:NUVPF) announces today that as per the news release dated October 23, 2017 it [...]

iKang Schedules 2017 Unaudited Second Quarter Earnings Release on December 14, 2017

28/11/2017 - 23:00

BEIJING, Nov. 28, 2017 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), major provider in China’s fast growing private preventive healthcare services market, today announced [...]

Teladoc Announces Proposed Sale of Shares of Common Stock

28/11/2017 - 22:47

PURCHASE, NY, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE: TDOC ) (“Teladoc”) today announced a proposed offering of shares of its common stock, which includes 3,250,000 shares offered by Teladoc and 830,000 [...]

Flexion Therapeutics to Present at Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference

28/11/2017 - 22:05

BURLINGTON, Mass., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that Michael Clayman, M.D., President and Chief Executive Officer, and Dan Deardorf, Senior Vice President [...]

Cytori Closes Rights Offering for Gross Proceeds of $10 Million

28/11/2017 - 22:05

SAN DIEGO, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc . (“Cytori”) (NASDAQ: CYTX ) announced today the closing of its rights offering (the “Rights Offering”) to subscribe for units at a subscription [...]

Iovance Biotherapeutics to Present at the Evercore ISI Biopharma Catalyst/Deep Dive Conference

28/11/2017 - 22:01

SAN CARLOS, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]

Ovid Therapeutics Announces OV101 Shows Comparable PK Profile in Phase 1 Study of Adolescent Patients and Amends Phase 2 STARS Clinical Trial Protocol to Include Adolescents

28/11/2017 - 22:00

-- Results from the Phase 1 Clinical Trial of Adolescents with Angelman and Fragile X Syndromes Demonstrated OV101 was Well Tolerated with a Pharmacokinetic Profile Similar to Adults -- -- With Core Expertise in [...]

Emblem Announces Third Quarter 2017 Financial Results

28/11/2017 - 22:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. ( “Emblem” or the “ Company ”) (TSXV:EMC), a vertically [...]

eRAD RIS Selected by Drs Schnetler, Corbett and Partners Radiology

28/11/2017 - 20:34

GREENVILLE, S.C., Nov. 28, 2017 (GLOBE NEWSWIRE) -- eRAD announced today that Drs Schnetler, Corbett and Partners Radiology (SCP Radiology) has selected eRAD’s Radiology Information System (RIS) to manage its clinical [...]

Arzeda Officially Closes Series A with Total $15.2 Million to Revolutionize Chemical Production with Protein Design

28/11/2017 - 20:33

SEATTLE, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Arzeda , The Protein Design Company TM , today announced that it has officially closed its Series A funding round with a total investment of $15.2 million. The company raised [...]

Discovery of Innate Immune Mechanisms of a Novel Microbial-based Approach for the Treatment of Lung Cancer

28/11/2017 - 18:43

VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc. (Qu), a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies designed to “ [...]